Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Clinical trial NCT03981705 · COMPLETED

Trial details

NCT number: NCT03981705
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Study type: OBSERVATIONAL

TN ER-/PR-/HER2- Breast Cancer Triple Negative Breast Cancer HER2-positive Breast Cancer ERany/PRany/HER2+ Breast Cancer

Start date: 2019-08-08
Primary completion: 2024-02-19
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.